PGIM INDIA HEALTHCARE FUND holds 33 instruments (94.89% equity), led by Divi's Laboratories Limited (10.36%), Sun Pharmaceutical Industries Limited (10.25%) and Torrent Pharmaceuticals Limited (8.49%), as of its 30 September 2026 SEBI-mandated monthly disclosure.
This page shows the complete disclosed portfolio of PGIM INDIA HEALTHCARE FUND, managed by PGIM India Mutual Fund, based on its monthly portfolio disclosure dated 30 September 2026. The fund holds 33 instruments with an equity allocation of 94.89%. Percentages are of net assets (% to NAV). Click any stock to see every other mutual fund that also holds it.
PGIM INDIA HEALTHCARE FUND's top 10 holdings account for 57.18% of its portfolio, more concentrated than the Thematic category average of 49.2%. Healthcare is its largest sector exposure at 88.16% of net assets, spread across 5 sectors in total. Since its 31 August 2026 disclosure, the fund added 2 new positions and exited 2 positions, with IPCA Laboratories Limited seeing the largest move (+1.41pp to 1.92%).
Equity holdings grouped by sector, % to NAV. "Other" covers debt, cash and other non-equity instruments, plus any equity holding without a classified sector.
Equity holdings compared between the fund's two latest monthly disclosures. Weights are % to NAV; weight moves can also reflect price changes, not only buying or selling.
| Stock | Weight | Change |
|---|---|---|
| IPCA Laboratories Limited | 0.51% → 1.92% | ▲ +1.41 |
| Gland Pharma Limited | 0.73% → 1.5% | ▲ +0.77 |
| ICICI Lombard General Insurance Company Limited | 1.4% → 2.1% | ▲ +0.7 |
| Dr Agarwals Eye Hospital Limited | 1.2% → 1.86% | ▲ +0.66 |
| Zydus Lifesciences Limited | 1.51% → 2.04% | ▲ +0.53 |
| Lupin Limited | 1.42% → 1.93% | ▲ +0.51 |
| Dr. Lal Path Labs Ltd. | 3.93% → 4.33% | ▲ +0.4 |
| Fortis Healthcare Limited | 1.1% → 1.46% | ▲ +0.36 |
| Abbott India Limited | 2.83% → 3.12% | ▲ +0.29 |
| Lenskart Solutions Limited | 0.71% → 0.99% | ▲ +0.28 |
| Stock | Weight | Change |
|---|---|---|
| Rubicon Research Limited | 4.01% → 2.99% | ▼ -1.02 |
| Sun Pharmaceutical Industries Limited | 10.74% → 10.25% | ▼ -0.49 |
| Divi's Laboratories Limited | 10.85% → 10.36% | ▼ -0.49 |
| MANIPAL HEALTH ENTERPRISES L | 4.12% → 3.68% | ▼ -0.44 |
| Torrent Pharmaceuticals Limited | 8.86% → 8.49% | ▼ -0.37 |
| Neuland Laboratories Limited | 3.26% → 2.91% | ▼ -0.35 |
| Aster DM Healthcare Limited | 2.89% → 2.56% | ▼ -0.33 |
| JUPITER LIFE LINE HOSPITALS | 1.77% → 1.46% | ▼ -0.31 |
| Max Healthcare Institute Limited | 4.96% → 4.71% | ▼ -0.25 |
| Global Health Limited | 1.72% → 1.52% | ▼ -0.2 |
% to NAV of the fund's current top holdings over its last 6 monthly disclosures (Apr – Sept 2026).
New to reading these? See How to Read a Mutual Fund's Monthly Portfolio Disclosure, or check terms like % to NAV in the glossary.
Source: PGIM India Mutual Fund's SEBI-mandated monthly portfolio disclosure, dated 30 September 2026. Data is for information only, not investment advice. Holdings may have changed since the disclosure date.